Voya Investment Management LLC Has $111.97 Million Stock Position in Kenvue Inc. (NYSE:KVUE)

Voya Investment Management LLC raised its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 22.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,244,684 shares of the company's stock after buying an additional 950,315 shares during the quarter. Voya Investment Management LLC owned 0.27% of Kenvue worth $111,974,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Sirios Capital Management L P bought a new stake in Kenvue during the 4th quarter worth approximately $423,000. MGO One Seven LLC raised its position in Kenvue by 12.2% in the 4th quarter. MGO One Seven LLC now owns 37,771 shares of the company's stock valued at $806,000 after buying an additional 4,116 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Kenvue by 3.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company's stock valued at $5,249,665,000 after acquiring an additional 8,211,748 shares in the last quarter. Hsbc Holdings PLC grew its stake in shares of Kenvue by 18.6% during the 4th quarter. Hsbc Holdings PLC now owns 3,369,706 shares of the company's stock worth $71,853,000 after acquiring an additional 527,506 shares in the last quarter. Finally, OneDigital Investment Advisors LLC grew its position in Kenvue by 3.8% in the fourth quarter. OneDigital Investment Advisors LLC now owns 19,252 shares of the company's stock valued at $411,000 after purchasing an additional 699 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on KVUE shares. Royal Bank of Canada reiterated a "sector perform" rating and set a $24.00 target price on shares of Kenvue in a report on Monday, February 3rd. Evercore ISI initiated coverage on shares of Kenvue in a research report on Monday, March 24th. They set an "in-line" rating and a $25.00 price target on the stock. Canaccord Genuity Group lifted their price target on Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a report on Wednesday, March 5th. Barclays cut their price objective on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Monday, April 14th. Finally, Piper Sandler increased their price target on Kenvue from $24.00 to $27.00 and gave the company an "overweight" rating in a research note on Monday, February 24th. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Kenvue presently has a consensus rating of "Hold" and an average target price of $24.42.

Kenvue Price Performance

NYSE:KVUE traded up $0.12 during trading hours on Wednesday, hitting $23.50. The company's stock had a trading volume of 2,255,519 shares, compared to its average volume of 17,041,716. The company has a market capitalization of $45.09 billion, a P/E ratio of 44.34, a PEG ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. The stock has a fifty day simple moving average of $23.06 and a 200-day simple moving average of $22.46. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th will be given a $0.205 dividend. The ex-dividend date is Wednesday, May 14th. This represents a $0.82 annualized dividend and a yield of 3.49%. Kenvue's dividend payout ratio is presently 154.72%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.